The rating affirmation is based on a number of factors, including FCGH’s strong market position, strengthened balance sheet and operating cash flow growth.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that FCGH will maintain a healthy balance sheet and continue to generate operating performance in line with its historical performance.
More articles on healthcare finance:
How Obama’s 2017 budget takes on surprise medical billing
Morgan Stanley buys 131,022 shares of athenahealth
ACP releases plan to address soaring drug prices
